East/West CEO: Developments in The Oncology Landscape
Dr. Charlene Liao, CEO of Immune-Onc Therapeutics, will speak at the East/West CEO conference.
Researchers find potential new way to target lethal form of leukemia
A report on our pioneering study in Nature describing a novel cancer immunotherapy target and potential treatment approach for acute myeloid leukemia (AML).
Two Genentech vets reunite at Immune-Onc to help steer its $33M drive to the clinic
A report on Immune-Onc’s key executives and Series B funding.
What You Need to Know About Immune-Onc Therapeutics
An interview with Dr. Charlene Liao, CEO, President and Co-Founder, Immune-Onc Therapeutics, Inc.
Top 20 Life Science Startups to Watch in 2018
Immune-Onc Therapeutics, Inc. is named one of the Top 20 up-and-coming life science companies.